Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2010 / Cilt: 20 - Sayı: 4

Larinks karsinomlarında fragil histidine triad gen ekspresyonu

Expression of the fragile histidine triad gene in laryngeal carcinoma

Pages
229–234
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, FHIT may be accepted to play a role in laryngeal squamous cell carcinoma tumorigenesis as a tumor suppressor gene.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to investigate Fragile Histidine Triad Gene (FHIT) expression in laryngeal squamous cell carcinoma.
📊
Key Findings & Data:The paraffin embedded tissue blocks of 64 laryngeal squamous cell carcinoma specimens were enrolled in the study.
💡
Conclusion & Impact:In conclusion, FHIT may be accepted to play a role in laryngeal squamous cell carcinoma tumorigenesis as a tumor suppressor gene.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of this study was to investigate Fragile Histidine Triad Gene (FHIT) expression in laryngeal squamous cell carcinoma. The paraffin embedded tissue blocks of 64 laryngeal squamous cell carcinoma specimens were enrolled in the study. FHIT expression was detected by an immunohistochemical method. Rabbit polyclonal antibody was used for immunohistochemical study. FHIT expression was low in 40.6% of patients and high in 59.6% of patients. Results were compared with clinicopathological variables. There was a significant correlation between high FHIT expression and lymph node metastasis (p<0.05). There was no significant correlation between FHIT expression and age, histological grade, perineural invasion and vascular invasion. In conclusion, FHIT may be accepted to play a role in laryngeal squamous cell carcinoma tumorigenesis as a tumor suppressor gene.

Özet

Bu çalışmanın amacı, skuamoz hücreli larinks karsinomlarında Fragile Histidine Triad Gene ( FHIT ) gen ekspresyonunu araştırmaktır. Bu çalışmaya 64 skuamoz hücreli larinks karsinomu spesmenine ait parafine gömülmüş doku blokları dahil edilmiştir. FHIT ekspresyonu immunhistokimyasal yöntem ile çalışılmıştır. İmmunhistokimyasal çalışmada tavşan poliklonal antikoru kullanılmıştır. FHIT ekspresyonu hastaların %40.6’sında düşük ve hastaların %59.6’unda yüksektir. Sonuçlar, klinikopatolojik değişkenlerle karşılaştırılmıştır. Yüksek FHIT ekspresyonu ile lenf nodu metastazı arasında anlamlı bir ilişki mevcuttur (p< 0.05). FHIT ekspresyonu ile yaş, histolojik derece, perinöral invazyon vasküler invazyon arasında anlamlı bir ilişki mevcut değildir. Sonuç olarak FHIT ‘in skuamoz hücreli larinks karsinomu tümör oluşumunda, tümör supresör gen olarak rol oynadığı kabul edilebilir.

🔖

Cite This Article

TUTAR, E., KARATAŞ, E., BAĞLAMA, T. (2010). Larinks karsinomlarında fragil histidine triad gen ekspresyonu. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 20 - Sayı: 4, 229–234. https://ajindex.com/articles/322966

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Vermund H, Krajci P, Eide TJ, Winther F. Laryngectomy whole organ serial sections--histological parameters correlated with recurrence rate. Acta Oncol 43: 98-107, 2004
  2. Yilmaz T, Hosal AS, Gediko¤lu G, et al. Prognostic significance of vascular and perineural invasion in cancer of the larynx. Am J Otolaryngol 19: 83-88, 1998
  3. Pekarsky Y, Zanesi N, Palamarchuk A, et al. FHIT: from gene discovery to cancer treatment and prevention. Lancet Oncol 3: 748-754, 2002
  4. Ohta M, Inoue H, Cottecelli MG, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597, 1996
  5. Siprashvili Z, Sozzi G, Barnes LD, et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 94: 13771-13776, 1997
  6. Mascaux C, Martin B, Verdebout JM, et al. Fragile histidine triad protein-expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53. Eur Respir J 21: 753-758, 2003
  7. Guler G, Uner A, Guler N, et al. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Cancer 100: 1605-1614, 2004
  8. Huang LW, Chao SL, Chen TJ. Reduced FHIT-expression in cervical carcinoma: correlation with tumor progression and poor prognosis. Gynecol Oncol 90: 331-337 2003
  9. Deng YF, Tian F, Lu YD, et al. Mutation and abnormal expression of the fragile histidine triad gene in nasopharyngeal carcinoma. Laryngoscope 111: 1589-1592, 2001
  10. Fouts RL, Sandusky GE, Zhang S, et al. Down-regulation of fragile histidine triad-expression in prostate carcinoma. Cancer 97: 1447-1452, 2003
  11. Tutar E, Kiyici H. Role of fragile histidine triad protein expression in pathogenesis of malignant pleural mesothelioma. Pathology 40: 42-45, 2008
  12. Altieri A, Bosetti C, Talamini R, et al. Cessation of smoking and drinking and the risk of laryngeal cancer. Br J Cancer 87: 1227-1229, 2002
  13. Soma T, Kaganoi J, Kawabe A, et al. Nicotine induces the fragile histidine triad methylation in human esophageal squamous epithelial cells. Int J Cancer 119: 1023-1027, 2006
  14. Tanimoto K, Hayashi S, Tsuchiya E, et al. Abnormalities of the FHIT gene in human oral carcinogenesis. Br J Cancer 82: 838-843, 2000
  15. Otero-Garcia JE, Youssef E, Enamorado II, et al. Prognostic significance of p53 and FHIT in advanced oropharyngeal carcinoma. Am J Otolaryngol 25: 231-239, 2004
  16. Wu R, Connolly DC, Dunn RL, Cho KR. Restored-